WINNIPEG—National animal law organization Animal Justice, the Winnipeg Humane Society (WHS), and a University of Manitoba biology professor are formally appealing a provincial permit allowing the City ...
Given the dramatic efficacy of warfarin, why is it not given to everyone with AF? Unfortunately, warfarin is a narrow therapeutic index drug affected by numerous factors. For AF, the optimal ...
Outcomes for acute, intermediate-risk pulmonary embolism are better with ultrasound-facilitated, catheter-directed fibrinolysis plus anticoagulation.
Observational data suggest apixaban leads to fewer thromboembolic events but higher bleeding risk, highlighting the need for ...
AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback. At an ...
Post-thrombotic syndrome is common after deep-vein thrombosis and can cause severe symptoms involving the limbs that impair patients’ activity and quality of life. Endovascular therapy can ...
Atrial fibrillation is a common but often silent heart condition, especially over 60. Learn the symptoms, risks and why early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results